The Clorox Company (NYSE:CLX) Shares Sold by Retirement Systems of Alabama

Retirement Systems of Alabama lessened its stake in The Clorox Company (NYSE:CLX) by 1.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,923 shares of the company’s stock after selling 473 shares during the quarter. Retirement Systems of Alabama’s holdings in Clorox were worth $4,386,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of CLX. Catalyst Capital Advisors LLC acquired a new stake in Clorox during the third quarter valued at approximately $54,000. AQR Capital Management LLC increased its holdings in shares of Clorox by 8.6% in the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company’s stock valued at $39,121,000 after acquiring an additional 22,676 shares during the last quarter. Los Angeles Capital Management LLC raised its position in shares of Clorox by 5.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock valued at $31,266,000 after acquiring an additional 10,149 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its stake in Clorox by 60.5% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company’s stock worth $3,244,000 after purchasing an additional 8,957 shares during the last quarter. Finally, Canada Pension Plan Investment Board boosted its holdings in Clorox by 1.6% in the second quarter. Canada Pension Plan Investment Board now owns 353,394 shares of the company’s stock worth $48,228,000 after purchasing an additional 5,500 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Up 1.5 %

NYSE CLX opened at $164.13 on Friday. The company has a market capitalization of $20.32 billion, a P/E ratio of 57.19, a PEG ratio of 3.04 and a beta of 0.42. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company’s 50 day simple moving average is $164.08 and its 200 day simple moving average is $152.48.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm’s revenue was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.49 earnings per share. Equities research analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.97%. Clorox’s dividend payout ratio (DPR) is 170.03%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CLX. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Citigroup upped their target price on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. StockNews.com raised Clorox from a “hold” rating to a “buy” rating in a report on Wednesday. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and upped their price objective for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Five research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and an average target price of $155.38.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.